Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Cardiff Oncology stock
Learn how to easily invest in Cardiff Oncology stock.
Cardiff Oncology Inc is a biotechnology business based in the US. Cardiff Oncology shares (CRDF) are listed on the NASDAQ and all prices are listed in US Dollars. Cardiff Oncology employs 22 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Cardiff Oncology
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CRDF – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Cardiff Oncology stock price (NASDAQ: CRDF)Use our graph to track the performance of CRDF stocks over time.
Cardiff Oncology shares at a glance
|Latest market close||$2.20|
|52-week range||$1.13 - $8.58|
|50-day moving average||$1.51|
|200-day moving average||$4.05|
|Wall St. target price||$12.67|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.84|
Buy Cardiff Oncology shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cardiff Oncology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cardiff Oncology price performance over time
|1 week (2022-06-24)||-3.08%|
|1 month (2022-06-01)||78.86%|
|3 months (2022-04-01)||-11.65%|
|6 months (2021-12-31)||-63.39%|
|1 year (2021-07-01)||-66.92%|
|2 years (2020-07-01)||-53.78%|
|3 years (2019-07-01)||2.52|
|5 years (2017-06-30)||74.60%|
Cardiff Oncology financials
|Gross profit TTM||$-17,017,000|
|Return on assets TTM||-16.04%|
|Return on equity TTM||-26.76%|
|Market capitalisation||$99.2 million|
TTM: trailing 12 months
Cardiff Oncology share dividends
We're not expecting Cardiff Oncology to pay a dividend over the next 12 months.
Have Cardiff Oncology's shares ever split?
Cardiff Oncology's shares were split on a 1:6 basis on 19 February 2019. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cardiff Oncology shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Cardiff Oncology shares which in turn could have impacted Cardiff Oncology's share price.
Cardiff Oncology share price volatility
Over the last 12 months, Cardiff Oncology's shares have ranged in value from as little as $1.13 up to $8.58. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cardiff Oncology's is 2.0304. This would suggest that Cardiff Oncology's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Cardiff Oncology overview
Cardiff Oncology, Inc. , a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc.
Frequently asked questionsWhat percentage of Cardiff Oncology is owned by insiders or institutions?
Currently 7.123% of Cardiff Oncology shares are held by insiders and 43.36% by institutions. How many people work for Cardiff Oncology?
Latest data suggests 22 work at Cardiff Oncology. When does the fiscal year end for Cardiff Oncology?
Cardiff Oncology's fiscal year ends in December. Where is Cardiff Oncology based?
Cardiff Oncology's address is: 11055 Flintkote Avenue, San Diego, CA, United States, 92121 What is Cardiff Oncology's ISIN number?
Cardiff Oncology's international securities identification number is: US14147L1089 What is Cardiff Oncology's CUSIP number?
Cardiff Oncology's Committee on Uniform Securities Identification Procedures number is: 897238101
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert